Effect of Continued Nutritional Support at Hospital Discharge on Mortality, Frailty, Functional Outcomes and Recovery
Launched by PHILIPP SCHUETZ · Jun 8, 2021
Trial Information
Current as of October 03, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether continued nutritional support after leaving the hospital can help patients who are at risk of malnutrition. The goal is to see if providing personalized nutrition plans that meet each patient’s energy and protein needs leads to better health outcomes compared to the usual home nutrition care. This study is open to adults aged 18 and older who have been identified as being at nutritional risk, which includes factors like significant weight loss or having serious health conditions such as cancer or chronic heart failure.
To participate, you would need to give your consent and meet specific health criteria, such as being a medical patient with a certain level of nutritional risk. However, there are some exclusions, like those who have recently had surgery or are unable to eat normally. If you join the trial, you can expect to receive extra nutritional support after you leave the hospital, which may help improve your recovery and overall health. This study is currently recruiting participants, and it aims to provide valuable insights into how nutrition impacts recovery for patients at risk of malnutrition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Informed Consent as documented by signature
- • Adult (age ≥18 years), medical patients
- • Nutritional risk screening using the Nutritional Risk Screening (NRS): total score ≥3 points consisting of ≥1 points for impairment of the nutritional status \[weight loss \>5% in 3 month or food intake of 50-75% in the last week before hospital admission\] plus ≥1 for the severity of the disease (i.e., cancer, chronic kidney disease, chronic heart failure, COPD) and other chronic diseases according to the definition of the "National Center for Chronic Disease Prevention and Health Promotion": Chronic diseases are defined broadly as conditions that last 1 year or more and require ongoing medical attention or limit activities of daily living or both .
- Exclusion Criteria:
- • after surgery
- • unable to ingest oral nutrition
- • need for long-term nutrition,
- • terminal condition
- • acute pancreatitis or acute liver failure
- • patients discharged to a nursing home
- • patients unlikely to comply with nutritional support treatment (e.g., dementia)
- • COVID-Hospitalisation requiring intensive care
About Philipp Schuetz
Philipp Schuetz is a distinguished clinical trial sponsor renowned for his commitment to advancing medical research and improving patient outcomes. With a strong background in internal medicine and a focus on innovative therapeutic approaches, Schuetz leads a team dedicated to conducting rigorous clinical trials that adhere to the highest ethical and scientific standards. His expertise spans multiple therapeutic areas, emphasizing the importance of evidence-based practice and collaboration with healthcare professionals. Under his guidance, the organization aims to facilitate the development of cutting-edge treatments while ensuring participant safety and data integrity throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valladolid, Spain
Zürich, Switzerland
Getafe, Spain
Münsterlingen, Thurgau, Switzerland
Lachen, Schwyz, Switzerland
Zürich, Switzerland
Málaga, Spain
Sankt Gallen, Switzerland
Aarau, Switzerland
Bern, Switzerland
Lucerne, Switzerland
Zofingen, Aargau, Switzerland
Burgdorf, Bern, Switzerland
Thun, Bern, Switzerland
Zürich, Switzerland
Barcelona, Spain
León, Spain
Madrid, Spain
Patients applied
Trial Officials
Philipp Schuetz, Prof. Dr. med.
Principal Investigator
Kantonsspital Aarau, University Department of Internal Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials